BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10648719)

  • 1. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.
    Bittencourt JC; Sawchenko PE
    J Neurosci; 2000 Feb; 20(3):1142-56. PubMed ID: 10648719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
    Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons.
    Sakamoto F; Yamada S; Ueta Y
    Regul Pept; 2004 May; 118(3):183-91. PubMed ID: 15003835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
    Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
    J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress.
    Imaki T; Shibasaki T; Hotta M; Demura H
    Brain Res; 1993 Jul; 616(1-2):114-25. PubMed ID: 8358602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain.
    Chan RK; Vale WW; Sawchenko PE
    Neuroscience; 2000; 101(1):115-29. PubMed ID: 11068141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U.
    Yokota M; Ozaki Y; Sakamoto F; Yamada S; Saito J; Fujihara H; Ueta Y
    Stress; 2004 Jun; 7(2):109-12. PubMed ID: 15512854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress.
    Imaki T; Shibasaki T; Wang XQ; Demura H
    Neuroendocrinology; 1995 Apr; 61(4):445-52. PubMed ID: 7783858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
    Lacroix S; Valliéres L; Rivest S
    J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats.
    Wang L; Martínez V; Vale W; Taché Y
    Brain Res; 2000 Feb; 855(1):47-57. PubMed ID: 10650129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration.
    Cespedes IC; de Oliveira AR; da Silva JM; da Silva AV; Sita LV; Bittencourt JC
    Peptides; 2010 Dec; 31(12):2200-8. PubMed ID: 20833218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus.
    Parkes D; Rivest S; Lee S; Rivier C; Vale W
    Mol Endocrinol; 1993 Oct; 7(10):1357-67. PubMed ID: 8264665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats.
    Maillot C; Wang L; Million M; Taché Y
    Brain Res; 2003 Jun; 974(1-2):70-81. PubMed ID: 12742625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.
    Pernar L; Curtis AL; Vale WW; Rivier JE; Valentino RJ
    J Neurosci; 2004 Feb; 24(6):1305-11. PubMed ID: 14960601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.
    Van de Kar LD; Javed A; Zhang Y; Serres F; Raap DK; Gray TS
    J Neurosci; 2001 May; 21(10):3572-9. PubMed ID: 11331386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
    Takahashi C; Ohata H; Shibasaki T
    Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourth ventricular CART peptide induces c-fos in the area postrema and nucleus of the solitary tract via a CRF-receptor dependent mechanism.
    Smedh U; Scott KA; Moran TH
    Neurosci Lett; 2015 Nov; 609():124-8. PubMed ID: 26475505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.